About Indo Us Bio-Tech Limited
Data last updated: 23 December 2025
Indo Us Bio-Tech Limited is a public limited company based in Ahmedabad, Gujarat, India. It specialises in seed production and distribution, a part of the broader agriculture sector. Incorporated on 04 February 2004, the company has been in operation for over 22 years.
Registered with ROC Ahmedabad under CIN L01122GJ2004PLC043550. Listed on BSE: 541304.
Capital: an authorised share capital of ₹32 Cr and a paid-up capital of ₹20.05 Cr. Formerly known as Pellucid Bio-Tech Private Limited and Indo Us Bio-Tech Private Limited. It is led by directors including Shilpa Chetanbhai Thumar and Nehaben Sachinbhai Patel.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 309 Shanti Mall Satadhar Char Rasta Opp. Navrang Tower Sola Road, Ahmedabad, Gujarat, India – 380061.
As per the financials filed for FY 2025, the company reported a revenue of ₹104.02 Cr, a growth of 42% compared to the previous year.
The company has a workforce of approximately 29 employees as per the latest available data.
The company is associated with 1 brand - Indo Us Bio-Tech. As per MCA filings, the company has open charges of ₹28.79 Cr and satisfied charges of ₹17.46 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website indousagriseeds.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered Address309 Shanti Mall Satadhar Char Rasta Opp. Navrang Tower Sola Road, Ahmedabad, Gujarat, India – 380061
-
IndustryAgriculture, Seed Production & Distribution
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Indo Us Bio-Tech Limited
Indo Us Bio-Tech Limited has undergone 3 name changes throughout its history. The company was previously known as Pellucid Bio-Tech Private Limited, Indo Us Bio-Tech Private Limited, and Pollucid Bio-Tech Private Limited. The current legal name is Indo Us Bio-Tech Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Indo Us Bio-Tech Limited | Current |
| Pellucid Bio-Tech Private Limited | Previous |
| Indo Us Bio-Tech Private Limited | Previous |
| Pollucid Bio-Tech Private Limited | Previous |
CIN History of Indo Us Bio-Tech Limited
Indo Us Bio-Tech Limited has one previous CIN (Corporate Identification Number): U01122GJ2004PTC043550. The current CIN is L01122GJ2004PLC043550, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L01122GJ2004PLC043550 | Current |
| U01122GJ2004PTC043550 | Previous |
Associated Brands with Indo Us Bio-Tech Limited
Indo Us Bio-Tech Limited operates one associated brand: INDO US BIO-TECH. These brands represent Indo Us Bio-Tech Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Producer and supplier of seeds | indousagriseeds.com |
Competitors & Alternatives of Indo Us Bio-Tech Limited
Brands and companies operating in the same space as Indo Us Bio-Tech Limited include Syngenta, Mahyco, Corteva Agriscience and 4 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Syngenta
|
Crop protection solutions and hybrid seeds are provided for farming. | Basel, Switzerland, Switzerland | 2000 |
Mahyco
|
Agriculture company offering hybrid and open pollinated seeds | Jalna, India, India | 1991 |
Corteva Agriscience
|
Manufacturer and supplier of agricultural farm inputs | Wilmington, United States, United States | 2017 |
Nuziveedu Seeds
|
Improved crop varieties and hybrids are developed and marketed. | Hyderabad, India, India | 1973 |
Protealis
|
Hybrid field crop seeds are supplied to farmers. | Ghent, Belgium, Belgium | 2021 |
PowerPollen
|
Hybrid corn seeds are produced and supplied using pollen technology. | Ankeny, United States, United States | 2015 |
NAPIGEN
|
Hybrid crop plants are developed using genome engineering techniques. | Wilmington, United States, United States | 2016 |
Business Activity of Indo Us Bio-Tech Limited
Indo Us Bio-Tech Limited is engaged in the principal business activity of agriculture, forestry, fishing, with detailed activities including production of crops and animals.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| A | Agriculture, forestry, fishing | A1 | Production of crops and animals | ********* |
Auditor Details of Indo Us Bio-Tech Limited
Indo Us Bio-Tech Limited is audited by M/s Gautam N Associates (ICAI peer reviewed, certificate valid till 2027-06-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| M/s Gautam N Associates (ICAI peer reviewed, certificate valid till 2027-06-30) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Indo Us Bio-Tech Limited
Indo Us Bio-Tech Limited is currently managed by 9 directors, with 13 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shilpa Chetanbhai Thumar | Director | 05 Aug 2021 | 4 Years 11 Months | Current |
|
Nehaben Sachinbhai Patel
Also directs:
Craft Finechem Llp
|
Director | 05 Aug 2021 | 4 Years 11 Months | Current |
| Priyanka Jagdishbhai Ajudia | Director | 23 Nov 2017 | 8 Years 7 Months | Current |
|
Malti Jagdishbhai Ajudia
Also directs:
Indo Us Organic Agri Private Limited, Indo-Us Agriseeds Limited
|
Whole-Time Director | 01 Nov 2008 | 17 Years 8 Months | Current |
| Jagdishkumar Devjibhai Ajudiya | Managing Director | 04 Feb 2004 | 22 Years 5 Months | Current |
|
Ritaben Nileshbhai Kikani
Also directs:
Kavyansh Pack Llp
|
Director | 01 Mar 2019 | 7 Years 4 Months | Current |
Financials of Indo Us Bio-Tech Limited FY 2026 filings available
Indo Us Bio-Tech Limited reported revenue of ₹110.44 Cr (up 6.36% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Revenue from Operations | ₹110.44 Cr | ₹103.84 Cr |
| Other Income | ₹5.42 Lakh | ₹18.2 Lakh |
| Total Income | ₹110.49 Cr | ₹104.02 Cr |
| Cost of Materials Consumed | ₹78.35 Cr | ₹70.96 Cr |
| Purchases of Stock-in-Trade | ₹31.17 Cr | ₹20.55 Cr |
| Changes in Inventories | -₹29.25 Cr | -₹18.85 Cr |
| Employee Benefit Expense | ₹1.42 Cr | ₹1.09 Cr |
| Finance Costs | ₹2.24 Cr | ₹1.49 Cr |
| Depreciation & Amortisation | ₹90.22 Lakh | ₹1.1 Cr |
| Other Expenses | ₹11.74 Cr | ₹11.15 Cr |
| Total Expenses | ₹96.57 Cr | ₹87.49 Cr |
| Profit Before Exceptional Items & Tax | ₹13.92 Cr | ₹16.53 Cr |
| Exceptional Items | ₹0 | ₹0 |
| Profit Before Tax | ₹13.92 Cr | ₹16.53 Cr |
| Total Tax Expense | ₹79.73 Lakh | ₹26.32 Lakh |
| Net Profit | ₹13.12 Cr | ₹16.27 Cr |
| Other Comprehensive Income | ₹58,000 | ₹52,000 |
| Total Comprehensive Income | ₹13.13 Cr | ₹16.27 Cr |
| EBITDA (computed) | ₹17.07 Cr | ₹19.12 Cr |
| Basic EPS | ₹6.54 | ₹8.12 |
| Diluted EPS | ₹6.54 | ₹8.12 |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Total Assets | ₹133.1 Cr | ₹97.84 Cr |
| Non-current Assets | ₹12.4 Cr | ₹11.12 Cr |
| Current Assets | ₹120.69 Cr | ₹86.73 Cr |
| Property, Plant & Equipment | ₹11.22 Cr | ₹10.23 Cr |
| Inventories | ₹99.95 Cr | ₹70.69 Cr |
| Trade Receivables | ₹13.76 Cr | ₹15 Cr |
| Cash & Equivalents | ₹6.12 Cr | ₹24.78 Lakh |
| Equity (Net Worth) | ₹92.53 Cr | ₹78.52 Cr |
| Equity Share Capital | ₹20.05 Cr | ₹20.05 Cr |
| Borrowings (Non-current) | ₹95.19 Lakh | ₹2.93 Cr |
| Borrowings (Current) | ₹36.08 Cr | ₹11.9 Cr |
| Total Debt (computed) | ₹37.04 Cr | ₹14.84 Cr |
| Current Liabilities | ₹39.52 Cr | ₹16.34 Cr |
| Total Liabilities | ₹40.56 Cr | ₹19.32 Cr |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Operating Cash Flow | -₹16.09 Cr | -₹1.42 Cr |
| Investing Cash Flow | ₹3.27 Cr | -₹79.24 Lakh |
| Financing Cash Flow | ₹24.44 Cr | -₹1.48 Cr |
| Capital Expenditure | -₹2.41 Cr | ₹0 |
| Free Cash Flow (computed) | -₹18.49 Cr | -₹1.42 Cr |
| Dividends Paid | ₹0 | ₹50.13 Lakh |
| Net Change in Cash | ₹11.88 Cr | -₹3.69 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|
| Revenue from Operations | ₹26.02 Cr | ₹22.8 Cr | ₹30.85 Cr | ₹30.77 Cr | ₹33.38 Cr | ₹22.17 Cr |
| Other Income | ₹2.15 Lakh | ₹50,000 | ₹2.62 Lakh | ₹15,000 | ₹11.95 Lakh | ₹1.52 Lakh |
| Total Income | ₹26.05 Cr | ₹22.8 Cr | ₹30.87 Cr | ₹30.77 Cr | ₹33.5 Cr | ₹22.19 Cr |
| Cost of Materials Consumed | ₹34.41 Cr | ₹15.6 Cr | ₹19.5 Cr | ₹8.84 Cr | ₹30.83 Cr | ₹11.14 Cr |
| Purchases of Stock-in-Trade | ₹3.08 Cr | ₹20.34 Cr | ₹59.76 Lakh | ₹7.15 Cr | ₹20.08 Cr | ₹9.37 Lakh |
| Changes in Inventories | -₹19.08 Cr | -₹19.96 Cr | ₹3.66 Cr | ₹6.13 Cr | -₹26.5 Cr | ₹3.3 Cr |
| Employee Benefit Expense | ₹43.36 Lakh | ₹33.04 Lakh | ₹33.68 Lakh | ₹32.06 Lakh | ₹33.63 Lakh | ₹24.23 Lakh |
| Finance Costs | ₹60.19 Lakh | ₹76.73 Lakh | ₹42.31 Lakh | ₹45.1 Lakh | ₹25.87 Lakh | ₹51.56 Lakh |
| Depreciation & Amortisation | ₹26.97 Lakh | ₹22.48 Lakh | ₹20.73 Lakh | ₹20.04 Lakh | ₹56.41 Lakh | ₹17.53 Lakh |
| Other Expenses | ₹3.95 Cr | ₹2.34 Cr | ₹2.6 Cr | ₹2.86 Cr | ₹4.05 Cr | ₹2.28 Cr |
| Total Expenses | ₹23.67 Cr | ₹19.64 Cr | ₹27.31 Cr | ₹25.95 Cr | ₹29.63 Cr | ₹17.74 Cr |
| Profit Before Exceptional Items & Tax | ₹2.38 Cr | ₹3.16 Cr | ₹3.56 Cr | ₹4.82 Cr | ₹3.88 Cr | ₹4.45 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹2.38 Cr | ₹3.16 Cr | ₹3.56 Cr | ₹4.82 Cr | ₹3.88 Cr | ₹4.45 Cr |
| Total Tax Expense | ₹40.65 Lakh | ₹16.66 Lakh | ₹10.68 Lakh | ₹11.75 Lakh | ₹19.44 Lakh | ₹8.63 Lakh |
| Net Profit | ₹1.97 Cr | ₹3 Cr | ₹3.45 Cr | ₹4.7 Cr | ₹3.68 Cr | ₹4.36 Cr |
| Other Comprehensive Income | -₹6,000 | -₹21,000 | -₹64,000 | ₹21,000 | ₹3.93 Lakh | -₹2.28 Lakh |
| Total Comprehensive Income | ₹1.97 Cr | ₹2.99 Cr | ₹3.45 Cr | ₹4.7 Cr | ₹3.72 Cr | ₹4.34 Cr |
| EBITDA (computed) | ₹3.25 Cr | ₹4.16 Cr | ₹4.19 Cr | ₹5.47 Cr | ₹4.7 Cr | ₹5.14 Cr |
| Basic EPS | ₹0.98 | ₹1.49 | ₹1.72 | ₹2.35 | ₹1.86 | ₹2.16 |
| Diluted EPS | ₹0.98 | ₹1.49 | ₹1.72 | ₹2.35 | ₹1.86 | ₹2.16 |
Shareholding Pattern of Indo Us Bio-Tech Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 68.29%, foreign institutional investors hold 0.18%, retail and other public shareholders hold 31.53% of Indo Us Bio-Tech Limited. The company had 4,531 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 68.29% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% |
| Public | 31.71% | 29.83% | 29.83% | 29.83% | 29.83% | 29.83% |
| Mar 2026 | Mar 2025 | |
|---|---|---|
| Promoters | 68.29% | 70.17% |
| Public | 31.71% | 29.83% |
| Promoter change (YoY, %pts) | -1.88 | - |
Board & Governance of Indo Us Bio-Tech Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Indo Us Bio-Tech Limited has 6 directors - 3 independent and 3 executive. The board is chaired by Jagdish Ajudia.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Jagdish Ajudia | Executive Director · CEO-MD · Chairperson | 2004-02-04 | 1 |
| Maltiben Ajudia | Executive Director | 2008-11-01 | 1 |
| Priyanka Ajudia | Executive Director | 2017-11-23 | 1 |
| Neha Patel | Non-Executive - Independent Director | 2021-08-05 | 0 |
| Shilpa Thumar | Non-Executive - Independent Director | 2021-08-05 | 0 |
| Ritaben Nileshbhai Kikani | Non-Executive - Independent Director | 2021-08-05 | 0 |
| Committee | Members |
|---|---|
| Audit Committee | Ritaben Nileshbhai Kikani (Chairperson), Shilpa Thumar, Jagdish Ajudia, Neha Patel |
| Nomination and remuneration committee | Shilpa Thumar (Chairperson), Ritaben Nileshbhai Kikani, Neha Patel |
| Stakeholders Relationship Committee | Ritaben Nileshbhai Kikani (Chairperson), Jagdish Ajudia, Neha Patel, Shilpa Thumar |
| Corporate Social Responsibility Committee | Jagdish Ajudia (Chairperson), Maltiben Ajudia, Ritaben Nileshbhai Kikani |
Charges & Borrowings of Indo Us Bio-Tech Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jun 2025 | Axis Bank Limited | ₹25.23 Cr | Open |
| 18 Apr 2023 | Axis Bank Limited | ₹2 Cr | Open |
| 20 Sep 2022 | Axis Bank Limited | ₹1.45 Cr | Open |
| 16 Jun 2022 | Others | ₹10.5 Lakh | Open |
| 09 Nov 2019 | Others | ₹11.41 Cr | Satisfied |
Total charge records: 8 View all charges
Employees and EPFO Compliance at Indo Us Bio-Tech Limited
Indo Us Bio-Tech Limited has a workforce of 29 employees as of Apr 08, 2024.
Employee Count & EPFO Data of Indo Us Bio-Tech Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Indo Us Bio-Tech Limited
GSTIN & GST Filing Data of Indo Us Bio-Tech Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Indo Us Bio-Tech Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Indo Us Bio-Tech Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Indo Us Bio-Tech Limited
MSME Payment Delays by Indo Us Bio-Tech Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Indo Us Bio-Tech Limited
Subsidiaries & Group Companies of Indo Us Bio-Tech Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Indo Us Bio-Tech Limited with ownership details.
MCA Filings & Documents of Indo Us Bio-Tech Limited
MCA Filings & Documents of Indo Us Bio-Tech Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Indo Us Bio-Tech Limited
Frequently Asked Questions about Indo Us Bio-Tech Limited
Indo Us Bio-Tech Limited is an active public limited company in the agriculture sector based in Ahmedabad, Gujarat, India. It was incorporated on 04 February 2004 (22+ years old) and is registered under CIN L01122GJ2004PLC043550. Listed on BSE: 541304. The company has 29 employees.
Indo Us Bio-Tech Limited reported revenue of ₹104.02 Cr for FY 2025 (up 42.00% YoY).
The current directors of Indo Us Bio-Tech Limited are:
- Shilpa Chetanbhai Thumar
- Nehaben Sachinbhai Patel
- Joshi Dimpy Divyangbhai
- Rinku Dipenbhai Jethva
- Priyanka Jagdishbhai Ajudia
- Malti Jagdishbhai Ajudia
- Jagdishkumar Devjibhai Ajudiya
- Ritaben Nileshbhai Kikani
- Dimpy Divyangbhai Joshi
The primary industry of Indo Us Bio-Tech Limited is agriculture. The company specifically operates in seed production and distribution. The company is currently active in this sector.
Yes. Indo Us Bio-Tech Limited is listed on BSE with code 541304.
Indo Us Bio-Tech Limited can be reached at the registered office: 309 Shanti Mall Satadhar Char Rasta Opp. Navrang Tower Sola Road, Ahmedabad, Gujarat, India – 380061, or through the website indousagriseeds.com.